Fiduciary Trust’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$538K Buy
5,955
+50
+0.8% +$4.59K 0.01% 556
2025
Q4
$531K Sell
5,905
-648
-10% -$61.4K 0.01% 542
2025
Q3
$645K Sell
6,553
-171
-3% -$16.9K 0.01% 503
2025
Q2
$613K Sell
6,724
-274
-4% -$26.5K 0.01% 498
2025
Q1
$792K Buy
6,998
+152
+2% +$16.3K 0.01% 439
2024
Q4
$723K Sell
6,846
-159
-2% -$17.1K 0.01% 419
2024
Q3
$756K Sell
7,005
-407
-5% -$44.4K 0.01% 407
2024
Q2
$804K Hold
7,412
0.01% 372
2024
Q1
$978K Sell
7,412
-9
-0.1% -$1.12K 0.02% 348
2023
Q4
$903K Sell
7,421
-2,012
-21% -$225K 0.02% 353
2023
Q3
$1.06M Sell
9,433
-360
-4% -$45.7K 0.02% 313
2023
Q2
$1.43M Sell
9,793
-227
-2% -$30.8K 0.03% 278
2023
Q1
$1.29M Sell
10,020
-400
-4% -$50.2K 0.02% 284
2022
Q4
$1.33M Sell
10,420
-5
-0% -$580 0.03% 290
2022
Q3
$1.09M Sell
10,425
-1,280
-11% -$140K 0.02% 303
2022
Q2
$1.23M Sell
11,705
-312
-3% -$37K 0.03% 293
2022
Q1
$1.54M Sell
12,017
-616
-5% -$74.3K 0.03% 288
2021
Q4
$1.56M Sell
12,633
-126
-1% -$16.5K 0.03% 285
2021
Q3
$1.81M Buy
12,759
+452
+4% +$66.5K 0.03% 256
2021
Q2
$1.92M Hold
12,307
0.04% 246
2021
Q1
$1.91M Buy
12,307
+1,241
+11% +$192K 0.04% 243
2020
Q4
$1.66M Buy
11,066
+241
+2% +$34K 0.03% 258
2020
Q3
$1.43M Sell
10,825
-124
-1% -$16.2K 0.03% 251
2020
Q2
$1.27M Sell
10,949
-86
-0.8% -$9.91K 0.03% 252
2020
Q1
$1.08M Sell
11,035
-4
-0% -$524 0.03% 250
2019
Q4
$1.6M Buy
11,039
+160
+1% +$22.1K 0.04% 229
2019
Q3
$1.45M Buy
10,879
+196
+2% +$25.3K 0.04% 233
2019
Q2
$1.22M Sell
10,683
-823
-7% -$96.4K 0.03% 240
2019
Q1
$1.43M Buy
11,506
+446
+4% +$50.7K 0.04% 218
2018
Q4
$1.11M Hold
11,060
0.03% 222
2018
Q3
$1.41M Hold
11,060
0.04% 221
2018
Q2
$1.2M Sell
11,060
-385
-3% -$41.9K 0.04% 230
2018
Q1
$1.21M Sell
11,445
-721
-6% -$83.7K 0.04% 232
2017
Q4
$1.43M Sell
12,166
-58
-0.5% -$6.56K 0.04% 224
2017
Q3
$1.39M Buy
12,224
+656
+6% +$75.7K 0.04% 215
2017
Q2
$1.44M Hold
11,568
0.04% 217
2017
Q1
$1.37M Sell
11,568
-371
-3% -$42K 0.04% 220
2016
Q4
$1.2M Sell
11,939
-381
-3% -$40.8K 0.04% 233
2016
Q3
$1.55M Sell
12,320
-103
-0.8% -$12.7K 0.05% 209
2016
Q2
$1.45M Hold
12,423
0.05% 213
2016
Q1
$1.29M Buy
12,423
+716
+6% +$69.3K 0.05% 225
2015
Q4
$1.17M Sell
11,707
-644
-5% -$63K 0.05% 204
2015
Q3
$1.13M Buy
12,351
+244
+2% +$24.5K 0.05% 198
2015
Q2
$1.28M Buy
12,107
+2,298
+23% +$254K 0.05% 186
2015
Q1
$1.12M Sell
9,809
-206
-2% -$23.5K 0.05% 195
2014
Q4
$1.1M Sell
10,015
-206
-2% -$21.7K 0.05% 203
2014
Q3
$997K Sell
10,221
-51
-0.5% -$5.02K 0.04% 190
2014
Q2
$1.04M Sell
10,272
-180
-2% -$17.6K 0.04% 189
2014
Q1
$960K Sell
10,452
-54
-0.5% -$4.98K 0.04% 186
2013
Q4
$951K Buy
10,506
+21
+0.2% +$1.82K 0.04% 184
2013
Q3
$836K Sell
10,485
-62
-0.6% -$4.88K 0.04% 184
2013
Q2
$767K Buy
+10,547
New +$789K 0.04% 187

Other funds holding ZBH

Fiduciary Trust's ZBH Position: Q1 2026 in Review

Fiduciary Trust increased its Zimmer Biomet (ZBH) stake by 0.85% in Q1 2026, buying an estimated $4.59K and bringing the position to 5,955 shares worth $538K. The position accounts for 0.01% of the portfolio, ranked #556.

Fiduciary Trust first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.92M in Q2 2021. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Fiduciary Trust held 5,955 shares of Zimmer Biomet worth $538K as of Q1 2026.
  • Fiduciary Trust bought 50 Zimmer Biomet shares in Q1 2026, an estimated $4.59K.
  • Zimmer Biomet made up 0.01% of Fiduciary Trust's portfolio in Q1 2026, its #556 holding.
  • Fiduciary Trust first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
  • Fiduciary Trust's Zimmer Biomet position peaked at $1.92M in Q2 2021.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Fiduciary Trust's 13F filing for Q1 2026, filed 15 May 2026.